A61K 40/438
Hemosporidia antigens
Official title: {Hemosporidia antigens, e.g. Plasmodium antigens}
A61K40/438 (Hemosporidia antigens) appears on 4 US grants and 12 published applications in this corpus.
Search patents in A61K- Granted patents
- 4
- Published applications
- 12
- Assignees
- 11
- Inventors
- 39
- Latest grant
- 10 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 2 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 3 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compositions comprising CelTOS immunogens and antibodies and method of use thereof10 Feb 2026US 12,544,441 B2University of South Florida
- Antigen-presenting platelets and methods of eliciting an immune response17 May 2016US 9,340,773 B2University of Rochester
- Inducing cellular immune responses to Plasmodium falciparum using peptide and nucleic acid compositions23 Feb 2016US 9,266,930 B1Epimmune Inc.
- Malaria associated antigen and preparing process thereof17 Feb 1987US 4,643,896 AOtsuka Pharmaceutical Co., Ltd.
- Catenated var2csa recombinant protein, preparation method therefor, and use thereof6 Mar 2025US 2025/0073269 A1CAS Lamvac (Guangzhou) Biomedical Technology Co., Ltd.
- Cytokine-induced killer cells16 May 2024US 2024/0156871 A1
- Compositions comprising celtos immunogens and antibodies and method of use thereof26 Oct 2023US 2023/0338536 A1University of South Florida
- Composition, A Treatment Method and An Application Thereof24 Sep 2020US 2020/0297781 A1Blue Elegant Biotech Co., Ltd.
- Anti-placenta-chondroitin-sulfate chimeric antigen receptor and application thereof23 May 2019US 2019/0153049 A1Guangzhou Cas Lamvac Biotech Co., Ltd.
Most cited
By later US patents